(Q43776120)

26 November 2017

title

A comparison of the effects of two continuous HRT regimens on cardiovascular risk factors (English)

1 reference

Hormone Replacement Therapy

26 November 2017

main subject

1 reference

Judith F Barnes

1

1 reference

26 November 2017

Elizabeth Farish

series ordinal

2

1 reference

26 November 2017

Marion Rankin

series ordinal

3

1 reference

26 November 2017

David M Hart

series ordinal

4

1 reference

26 November 2017

publication date

1 January 2002

1 reference

26 November 2017

1 reference

26 November 2017

volume

160

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

185-193

1 reference

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Decreased mortality in users of estrogen replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Hormone therapy to prevent disease and prolong life in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Lp(a) lipoprotein: relationship to cardiovascular disease risk factors, exercise, and estrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Lipoprotein (a) concentrations in postmenopausal women taking norethisterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Role of oxidized low density lipoprotein in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Effect of combined 17β-estradiol and vitamin E on low-density lipoprotein oxidation in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Effects of estrogen replacement therapy on plasma levels of nitric oxide in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

A rapid semi-micro method for the separation of lipoprotein fractions that uses a benchtop ultracentrifuge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Effects of tibolone on lipoprotein(a) and HDL subfractions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

A rapid method for measurement of the susceptibility to oxidation of low-density lipoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Org OD 14: long-term effects on serum lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

High resolution ultrasound assessment of the carotid artery: its relevance in postmenopausal women and the effects of tibolone on carotid artery ultrastructure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Estrogen-induced small low-density lipoprotein particles in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Changes in the low-density lipoprotein profile during 17 beta-estradiol-dydrogesterone therapy in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Impact of combined hormone replacement therapy on serum lipid metabolism: new aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Tibolone prevents atherosclerotic lesion formation in cholesterol-fed, ovariectomized rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Estrogens inhibit copper and cell-mediated modification of low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

The inhibition of low-density lipoprotein oxidation by 17-beta estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

The effect of various oestrogens and progestogens on the susceptibility of low density lipoproteins to oxidation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Decrease of serum endothelin levels with postmenopausal hormone replacement therapy or tibolone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Effect of tibolone on glucose and lipid metabolism in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Postmenopausal hormone therapy and coronary heart disease: clinical implications of recent randomized trial results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

Change in LDL particle size is associated with change in plasma triglyceride concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900560-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(01)00560-3

1 reference

26 November 2017

1 reference